InvestSMART

Mach7 Technologies Limited (ASX: M7T) - Share Price

Current share price for M7T : $0.290 0.01 (3.57%)+

Mach7 Technologies Limited (M7T) is an ASX-listed company and is not held by any exchange traded funds (ETFs). It , is a provider of medical imaging software, delivering data management and diagnostic viewing solutions to healthcare organisations worldwide.

M7T General Information +

ASX Code M7T
Website http://www.mach7t.com
Industry/Sector Health Care Technology
Market Cap ($M) 68
M7T Share Price $0.290
Day High $0.290
Day Low $0.280
Last Close $0.280
M7T Share Price Movement $0.01 ( 3.57% )
Prices as at 16:40, 1 Sep 2026
+Security prices are delayed by at least 20 minutes and are indicative only.

Mach7 Technologies Limited (M7T) Upcoming Dividends & Yields

Distribution Type Dividend Franking Ex-dividend date Payment date Current Price+ Price 7D Avg Dividend Yield

See all dividends from Mach7 Technologies Limited (M7T) or use our Upcoming Dividends tool to search for dividends across all ASX-listed securities.

Mach7 Technologies Limited (M7T) price-sensitive announcements

M7T - Quarterly Activities/Appendix 4C Cash Flow Report
Mach7 Technologies Limited, an enterprise imaging software provider, issued its Q4 FY26 bu
Mach7 Technologies Limited (M7T)
29 Jul 2026 | 8:49 AM
M7T - M7T Signs New Customer, Shortens Sales, Deployment Timeframe
Mach7 Technologies Limited has announced a new contract with American Radiologist Network
Mach7 Technologies Limited (M7T)
20 May 2026 | 9:41 AM
M7T - Q3 FY26 Results Presentation
Mach7 Technologies Limited's Q3 FY26 results presentation highlights a solid financial pos
Mach7 Technologies Limited (M7T)
24 Apr 2026 | 8:34 AM
M7T - Quarterly Activities/Appendix 4C Cash Flow Report
Mach7 Technologies Limited has reported positive operating cashflow for the third quarter
Mach7 Technologies Limited (M7T)
24 Apr 2026 | 8:30 AM

Mach7 Technologies Limited (M7T) Recent ASX Announcements

Company Sector Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
Mach7 Technologies Limited (M7T)
ORDINARY FULLY PAID
 Health Care $68 Notification of cessation of securities - M7T 1 Sep 2026 10:10AM $0.280 $0.290 risen by 3.57%
Mach7 Technologies Limited (M7T)
ORDINARY FULLY PAID
 Health Care $68 FY26 Result Presentation 28 Aug 2026 8:22AM $0.275 $0.290 risen by 5.45%
Mach7 Technologies Limited (M7T)
ORDINARY FULLY PAID
 Health Care $68 FY26 Result 28 Aug 2026 8:20AM $0.275 $0.290 risen by 5.45%
Mach7 Technologies Limited (M7T)
ORDINARY FULLY PAID
 Health Care $68 Preliminary Final Report and Audited Financial Statements 28 Aug 2026 8:20AM $0.275 $0.290 risen by 5.45%
Mach7 Technologies Limited (M7T)
ORDINARY FULLY PAID
 Health Care $68 Notification of cessation of securities - M7T 24 Aug 2026 3:06PM $0.280 $0.290 risen by 3.57%
Mach7 Technologies Limited (M7T)
ORDINARY FULLY PAID
 Health Care $68 Change in substantial holding 17 Aug 2026 11:32AM $0.280 $0.290 risen by 3.57%

M7T Financial Summary

Year to Jun NPAT EPS EPS chg (%) PER DPS Yield (%) Franking (%)
2027F C2 -$2.60 -27.80% 0.00 0.00 0.00% 0.0%
2026F C2 -$3.60 39.50% 0.00 0.00 0.00% 0.0%
2025A -$6.20 -$2.60 -22.10% 0.00 0.00 0.00% 0.0%

M7T Peer Comparison

Company Mkt Cap EPS Growth (%) P/E (%) Dividend Yield (%)
2025 A 2026 F 2027 F 2025 A 2026 F 2027 F 2025 A 2026 F 2027 F
4DMedical Limited (4DX) $2,184M 1.4982 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Mach7 Technologies Limited (M7T) $67M -0.2205 0.0000 0.0000 0.0000 0.0000 0.0000 0.00% 0.00% 0.00%
Pro Medicus Limited (PME) $18,959M 1.3034 -0.2811 0.2395 71.5615 99.5447 80.3080 0.38% 0.51% 0.63%

M7T Market Comparison

Earnings P/E Ratio P/B Ratio P/E Growth
Company 0.00 0.00 1.44 0.00
Market 0.37 13.40 1.17 0.80
Sector 0.63 21.10 1.80 3.03

M7T Directors

Name Position Start Date
Ms Teri Jo Thomas Chief Executive Officer, Managing Director 1 Jul 2025
Mr Robert John Bazzani Non-Executive Chairman, Non-Executive Director 1 Jan 2020
Dr Eliot L Siegel Non-Executive Director 3 Aug 2018
Ms Rebecca Thompson Non-Executive Director 16 Nov 2023

Mach7 Technologies Limited (M7T) Changes in Directors' Interest & Trades

Date of change Director Buy/Sell Security Type Qty Trade Price Value
22 May 2026 THOMAS, Teri Buy Direct Shares 200,000 $0.318 $63,500.000
31 Mar 2026 THOMAS, Teri Buy Direct Shares 50,000 $0.280 $14,000.000
31 Mar 2026 SIEGEL, Eliot Buy Direct Shares 454,422 $0.320 $145,415.040

See all changes in directors' interest & trades for Mach7 Technologies Limited (M7T) or use our Changes in directors' interest tool to search for changes & trades across all ASX-listed securities.

M7T Management

Name Position
Dyan O'Herne Chief Financial Officer
David Madaffri Chief Operating Officer
Naomi Lawrie Company Secretary

M7T Substantial Shareholders

Under ASX rules large investors and investment funds must disclose when they own more than a 5% stake in Mach7 Technologies Limited (M7T). However, you won't necessarily see their names in the company’s annual report, as many trade under nominee names. These shareholders are obliged to provide ongoing substantial notices relating to any change of 1% or more.

Holding Name
34,886,014 (14.46%) Australian Ethical Investment Limited
28,372,672 (11.76%) JM Financial Group Limited
22,319,888 (9.50%) Microequities Asset Management Pty Ltd

M7T Calendar of Events

Date Event
27 August 2027 Report (Prelim)
26 February 2027 Report (Interim)
28 October 2026 Report (Annual)

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.